Studies have found that impaired brain insulin-PI3K-AKT signaling may promote neurodegeneration in Alzheimer’s disease (AD) by downregulating O-GlcNAcylation, subsequently promoting abnormal tau hyperphosphorylation and neurofibrillary degeneration (Liu et al., 2011b). Here, AKT1 is linked to Alzheimer disease.